Assistant

Stowers Institute for Medical Research appoints new Assistant Investigator

Retrieved on: 
Tuesday, April 30, 2024

KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute for Medical Research announces the appointment of Kamena Kostova, Ph.D., as its newest Principal Investigator. Kostova, an accomplished cellular and molecular biologist, will join the Institute as an Assistant Investigator in Fall 2024.

Key Points: 
  • Kamena Kostova, Ph.D., a molecular biologist from Carnegie Science, will open her lab at the Stowers Institute in Fall 2024.
  • KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute for Medical Research announces the appointment of Kamena Kostova, Ph.D. , as its newest Principal Investigator.
  • Kostova, an accomplished cellular and molecular biologist, will join the Institute as an Assistant Investigator in Fall 2024.
  • "We are delighted to welcome and count Dr. Kamena Kostova as our newest Principal Investigator at the Stowers Institute," said Alejandro Sánchez Alvarado, Ph.D. , President and Chief Scientific Officer of the Stowers Institute.

NEW BLUE, AN INCUBATOR FOR FORWARD-THINKING POLICE OFFICERS, OFFERS SOLUTIONS TO POLICE RECRUITMENT CRISIS AT DEPARTMENT OF JUSTICE CONVENING

Retrieved on: 
Monday, April 29, 2024

WICHITA, Kan., April 29, 2024 /PRNewswire/ -- The Bureau of Justice Assistance convened top practitioners in the policing field, academics, and other stakeholders on April 16-17  at Wichita State University for the Criminal Justice Workforce of the Future Convening. Building on BJA's Recruitment & Retention roundtable last year, the convening aimed to address an assessment of workforce and career pipelines in criminal justice, and create new strategies for recruitment and retention.

Key Points: 
  • Building on BJA's Recruitment & Retention roundtable last year, the convening aimed to address an assessment of workforce and career pipelines in criminal justice, and create new strategies for recruitment and retention.
  • "In order to recruit the next generation, police departments will have to align their culture with Gen Z values."
  • Traditional operating standards within a police department do not align with the values and ideals of the incoming generation of workers.
  • New Blue is an incubator for forward-thinking police to collaborate with their communities, developing solutions that build trust through policy and practice.

Boston IVF Welcomes Dr. Josette Dawkins to its Springfield Fertility Center, Further Enhancing Access to Expert Reproductive Care in Western Massachusetts

Retrieved on: 
Monday, April 29, 2024

SPRINGFIELD, Mass., April 29, 2024 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce the addition of reproductive endocrinologist, Dr. Josette Dawkins, MD to its Springfield, MA fertility center and team.

Key Points: 
  • The addition of Dr. Josette Dawkins to Boston IVF and its fertility clinic in Springfield enriches the accessibility of timely reproductive care for individuals seeking to start a family.
  • She joins Boston IVF from Baystate Reproductive Medicine in Springfield, MA – where she served as its Medical Director.
  • "We are thrilled to extend a warm welcome to Dr. Josette Dawkins as she joins our esteemed Boston IVF team in Springfield, Massachusetts," expressed David Stern, CEO of Boston IVF.
  • "I am honored to become part of the respected team at Boston IVF," said Dr. Josette Dawkins.

EQS-News: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

Retrieved on: 
Friday, May 3, 2024

Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

Key Points: 
  • Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need
    MD Anderson responsible for leading initial Phase 1/2 studies; CureVac retains worldwide exclusive rights to late-stage development, commercialization, or partnering of cancer vaccine candidates
    TÜBINGEN, Germany/HOUSTON, Texas, USA – April 16, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and The University of Texas MD Anderson Cancer Center today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines.
  • The collaboration creates strong synergies between CureVac’s unique end-to-end capabilities for cancer antigen discovery, mRNA design, and manufacturing and MD Anderson’s expertise in cancer antigen discovery and validation, translational drug development, and clinical research.
  • The collaboration will focus on the development of differentiated cancer vaccine candidates in selected hematological and solid tumor indications with high unmet medical need.
  • “We are excited for cancer vaccines to potentially emerge as an essential therapeutic tool in the future,” Shukla said.

Kudos Launches AI-Powered Recognition Assistant to Streamline Employee Recognition

Retrieved on: 
Thursday, April 25, 2024

Kudos' newest feature, powered by AI, promises to transform how employees and leaders give recognition to boost engagement, reduce turnover, and improve performance.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - April 25, 2024) - Kudos® , a leading provider in employee recognition and rewards, today announced the launch of its innovative Recognition Assistant, an AI-powered feature designed to refine and simplify employee recognition.
  • The Kudos Recognition Assistant uses generative AI to help users craft more impactful and meaningful messages while tailoring them to individual achievements and occasions.
  • With the Recognition Assistant, Kudos leverages over a decade of expertise in employee recognition to offer a user-friendly solution that generates customized, resonant messages from basic user inputs.
  • The Kudos Recognition Assistant complements the platform's growing suite of employee recognition and engagement tools.

Tara L. French Elected to BCB Bancorp, Inc. and BCB Community Bank Boards of Directors

Retrieved on: 
Thursday, May 2, 2024

BAYONNE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank” or “BCB”), today announced the election of Tara L. French to the Board of Directors of both BCB Bancorp, Inc. and BCB Community Bank, effective immediately.

Key Points: 
  • BAYONNE, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank” or “BCB”), today announced the election of Tara L. French to the Board of Directors of both BCB Bancorp, Inc. and BCB Community Bank, effective immediately.
  • Ms. French previously was an officer at Northfield Bank until her retirement in June 2023.
  • She joined Northfield in 2017 as the Chief Administrative Officer, and she was named Chief Risk Officer in September 2020.
  • “We are delighted to welcome Ms. French to our Boards of Directors and look forward to working with her as we pursue our mission to grow our franchise,” said Mr. Mark D. Hogan, Chairman of the Board.

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

Retrieved on: 
Wednesday, April 24, 2024

BELTSVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that clinical trial investigator Eric S. Christenson, M.D., Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, will present a poster on clinical data from the Phase 1b portion of a study evaluating NC410 in combination with pembrolizumab at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 – June 4 in Chicago.

Key Points: 
  • BELTSVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that clinical trial investigator Eric S. Christenson, M.D., Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, will present a poster on clinical data from the Phase 1b portion of a study evaluating NC410 in combination with pembrolizumab at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 – June 4 in Chicago.
  • Title: A phase 1b study of NC410 in combination with pembrolizumab in immune checkpoint inhibitor (ICI) naïve, and refractory microsatellite stable (MSS)/microsatellite instability-low (MSI-L) colorectal cancer (CRC) and ovarian cancer

Peapack-Gladstone Bank Promotes Kate Sant'Angelo to Senior Vice President, Director of Personal Banking

Retrieved on: 
Friday, April 19, 2024

BEDMINSTER, NJ, April 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack-Gladstone Bank, announce the elevation of Kate Sant’Angelo to Senior Vice President, Director of Personal Banking.

Key Points: 
  • BEDMINSTER, NJ, April 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack-Gladstone Bank, announce the elevation of Kate Sant’Angelo to Senior Vice President, Director of Personal Banking.
  • As the lead for retail banking, Kate oversees the Bank’s retail branch network, branch operations, client experience training and retail administration functions and responsibilities, with a focus on the Bank’s strategic initiatives.
  • With 22 years of experience in the banking industry, Kate previously served at Lakeland Bank and subsequently at Wells Fargo as Assistant Vice President, Branch Manager in Branchburg and Bridgewater, NJ.
  • Joining Peapack-Gladstone Bank in 2015, she held the positions of Vice President, Retail Private Banker and Vice President, Retail Administration in the Bank’s Bedminster headquarters location.

Carahsoft and 70+ Partners Demonstrate Innovative AI, Geospatial & Cloud Solutions at GEOINT on May 5-8, 2024

Retrieved on: 
Thursday, April 18, 2024

Government officials, industry experts and thought leaders will gather to discuss emerging trends and innovative technology applications for today’s evolving geopolitical landscape.

Key Points: 
  • Government officials, industry experts and thought leaders will gather to discuss emerging trends and innovative technology applications for today’s evolving geopolitical landscape.
  • Attendees have a front seat to the GEOINT community’s advancements through educational sessions, meaningful networking opportunities and technology demonstrations showcasing modern solutions to present day challenges.
  • More than 200 speakers will share their expertise across a variety of GEOINT sessions, encompassing keynotes, panels, fireside chats, training sessions, working group meetings as well as tracks for innovation and Government.
  • Scott Bray, Assistant Secretary General for Intelligence and Security, North Atlantic Treaty Organization (NATO)

Augustine Casino Ups Their Game with QCI Slots: A New Era of Data-Driven Gaming Innovation Begins

Retrieved on: 
Wednesday, April 17, 2024

Building on the success of their partnership with QCI Host, Augustine Casino is poised to revolutionize the gaming experience for its patrons.

Key Points: 
  • Building on the success of their partnership with QCI Host, Augustine Casino is poised to revolutionize the gaming experience for its patrons.
  • Elizabeth Wilberts, Assistant General Manager of Augustine Casino, expressed her excitement about integrating QCI Slots into their operations, stating, "We are thrilled to expand our collaboration with QCI by incorporating their cutting-edge Slots solution.
  • Now, with the addition of QCI Slots, Augustine Casino is poised to set new standards for excellence in the industry.
  • "The decision to integrate QCI Slots underscores Augustine Casino's commitment to leveraging innovative technology to elevate the gaming experience."